Impact Biomedical Inc.
NYSE · Healthcare · Pharmaceutical Preparations · West Henrietta, NY
IBO chart
What traders are saying about $IBO
Latest postsImpact Biomedical Inc. news
- Impact BioMedical 3Q 2026: Revenue $21K, EPS ($0.08) — 10-Q Summary
TradingView ·
- With $1.62M due on demand, Impact BioMedical (IBO) warns about its ability to keep operating.
Stock Titan ·
- Impact BioMedical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
www.marketscreener.com ·
- Form 4 Impact Biomedical Inc: Melissa Kaye Sims (Director) For: 7 October
Investing.com Nigeria ·
- COO Mark Suseck reports a transaction at $4.54 per share in Impact Biomedical (IBO).
Stock Titan ·
- A 4,170-share disposition leaves Impact Biomedical (IBO) director Zimmerman holding 32,112 shares directly.
Stock Titan ·
- Director Keene disposes of Impact Biomedical (IBO) shares, leaving reported direct holdings of 32,112.
Stock Titan ·
- Director disposes of 4,170 Impact Biomedical (IBO) shares under an equity incentive plan.
Stock Titan ·
- After disposing of 4,170 shares, Impact Biomedical (IBO) CFO Todd D. Macko holds 16,462 directly.
Stock Titan ·
- DSS, Inc. Announces SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business Combination
Yahoo Finance ·
- Impact Biomedical Inc. and Zoar Limited Announce SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business Combination
Yahoo Finance ·
- DSS, Inc. Announces Form F-4 Filing in Connection with Impact Biomedical’s Proposed Business Combination with Zoar Limited
Yahoo Finance ·
Impact Biomedical Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $32,000 | – | – | $50,000 |
| Net income | -$11.8M | -$24.7M | -$4.3M | -$7.3M |
| Diluted EPS | $-0.38 | $-2.30 | $-0.07 | $-0.10 |
| Total assets (year end) | $17.4M | $20.3M | $44.6M | $46.5M |
| Cash and equivalents (year end) | $3,000 | $2.0M | $1,000 | $2,000 |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Impact Biomedical Inc.
- Ticker
- IBO (NYSE)
- Industry
- Pharmaceutical Preparations
- Headquarters
- West Henrietta, NY
- Incorporated in
- NV
- Fiscal year end
- December 31
- SEC CIK
- 1834105
Frequently asked questions
What exchange is Impact Biomedical Inc. listed on?
Impact Biomedical Inc. trades on the NYSE under the ticker symbol IBO.
What industry is Impact Biomedical Inc. in?
Impact Biomedical Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Impact Biomedical Inc. headquartered?
Impact Biomedical Inc.'s business address on file with the SEC is in West Henrietta, NY.
When does Impact Biomedical Inc.'s fiscal year end?
Impact Biomedical Inc.'s fiscal year ends on December 31.
How much revenue did Impact Biomedical Inc. report?
Impact Biomedical Inc. reported $32,000 in revenue for calendar year 2025, according to its SEC filings.